-
-
-
-
-
-
-
Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs
-
-
-
-
-
-
-
Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop
-
-
-
-
-
-
-
Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment
-
-
-
-
-
-
-
Humacyte Presents Advances in Whole-Lung Engineering
-
-
-
-
-
-
-
Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank
-
-
-
-
-
-
-
Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

